Countdown toNOPAIN Act:
Days
ASP+6% CMS reimbursement for proven non-opioids used in all outpatient surgical settings is coming January 1, 2025.
Learn more about our therapies by selecting a product below.
EXPAREL® (bupivacaine liposome injectable suspension) is a local analgesic administered at the time of surgery to control pain and reduce or eliminate the use of opioids for acute postsurgical pain.*
The ioverao system is a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves, interrupting the nerve’s ability to transmit a pain signal.
Proprietary multivesicular liposome (pMVL) technology encapsulates drugs, preserving their molecular structure, and releases them over a desired period of time.
ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) is the first and only approved treatment for osteoarthritis (OA) knee pain utilizing extended-release microsphere technology.